Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy - Wikidata - wikimedia - TriplyDB

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q26999424

about

Recent advances in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.High-frame rate four dimensional optoacoustic tomography enables visualization of cardiovascular dynamics and mouse heart perfusion Review of Journal of Cardiovascular Magnetic Resonance 2012.Review of Journal of Cardiovascular Magnetic Resonance 2013 In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Solitary accessory and papillary muscle hypertrophy manifested as dynamic mid-wall obstruction and symptomatic heart failure: diagnostic feasibility by multi-modality imaging.A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation Relation of late gadolinium enhancement in cardiac magnetic resonance on the diastolic volume recovery of left ventricle with hypertrophic cardiomyopathy.Determining the role of fibrosis in hypertrophic cardiomyopathy.Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries.Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy Do big athletes have big hearts? Impact of extreme anthropometry upon cardiac hypertrophy in professional male athletes.Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry.Nonobstructive hypertrophic cardiomyopathy with left ventricular aneurysm: the role of cardiac magnetic resonance.Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance.The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.Hypertrophic cardiomyopathy: The need for randomized trials Insights and challenges in hypertrophic cardiomyopathy, 2012.The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles.Advances of cardiovascular MRI in hypertrophic cardiomyopathy.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Kinetic index combining native and postcontrast myocardial T1 in hypertrophic cardiomyopathy.Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis.Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.Discrimination of the "Athlete's Heart" from real disease by electrocardiogram and echocardiogram.Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers.Exuberant pattern of late gadolinium enhancement in hypertrophic cardiomyopathy.The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy.Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion.Apical hypertrophic cardiomyopathy in an Indian patient: straight from the book.Highlights of the 16th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance.Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

P2860

Q26998648-4B2AF904-4BFD-497A-AE98-1B7CC1B48CBC Q30278822-5B8A4F00-1342-4992-8097-E1E9848AAB41 Q30355765-09BAB18D-10E5-46BC-8775-15DA2FC451D3 Q30407310-95E38348-B68A-4E13-9339-2A36A88FA40F Q30446298-DF47E93E-DDF1-459E-829F-2F4C050A6A9F Q30487473-6BBFEC49-594F-4DE7-9FF5-C2439563C550 Q30868844-3F69F8BE-5171-48B6-ABFD-9853DBC5DF67 Q33168755-631D0748-4BA2-4948-BA28-EC111760343F Q33588177-F0552B9E-0A2F-4C3C-B318-8CD151CF6C31 Q33729245-186C42A4-DF46-4523-90C8-E447BF51917B Q33995246-07F97265-017E-4707-97DE-BDE9988BF250 Q34660599-8AD778CC-C522-4794-A236-A255F6BE7EBF Q35899352-B329A6B1-4A6A-4A33-8DBE-B7C3DA54FAA7 Q36203429-D881AA37-B5B9-4921-BF26-2E1C509D6251 Q36235564-50BB30E6-56E8-4A2E-859C-3F48E29EEFC6 Q36412765-167A477B-7DA1-4096-A75A-3557C20EE3D4 Q36552532-D358C625-8095-43B0-84FC-B1E3D9FD5D10 Q36702994-3F497A5A-892D-4298-AC2D-88D4FB6DE867 Q36851500-FF2521EB-03FA-4B1E-B2D6-21361AD068A8 Q37197744-670AB4BB-7A6A-4D68-AB04-EA18CDB3F8DE Q37410737-2BC76135-1D3C-4471-A436-A38F914BED40 Q37596065-5822CA85-9912-4DBA-A901-E85C78C3C0BA Q37659240-7D70DBE4-340C-4D75-86B7-FC9C6811C699 Q38046158-385AD550-D9A4-4A5A-9F2E-D43C7991B3E3 Q38068352-ABFCB368-687B-4F4A-83FC-47EE4EED67B9 Q38103225-0E026954-BE0C-4E90-BCCE-C52A407F9401 Q38135893-476561A1-5690-451E-AD87-370433486BFA Q38343713-1A56783F-B248-476C-B510-B6F55C84BB3E Q38484413-91C008CF-2E44-48DE-9920-91D427F673B4 Q38523144-CF077158-2E2E-48CF-924E-E4A5A4029D20 Q38823957-FBE96464-8E6B-4291-BE65-D2784084333F Q39085573-53F1F3B9-446B-4BA2-9A26-C11038188057 Q39388903-6A94A27F-2D47-4040-BD73-9C0615EEFAAE Q40296177-86831F0A-E365-4334-B4A4-AAEC38DD5016 Q40853628-DDB12D51-7B49-43B5-B224-1ED877A63361 Q41270510-547ED7EA-6686-43AD-AD12-1019117EEB6D Q42180004-F96AF934-E32B-4399-861C-A6D52941B29A Q42266198-68350D67-2F99-4C61-9235-8821D201B0F9 Q43069669-6C47CAE9-A9EC-438B-8DA7-B9BFB5C3DA04 Q45921977-B9EBB299-011F-400F-8357-A5794F507115

P2860

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q26999424

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@ast

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@en

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@nl

type

label

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@ast

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@en

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@nl

prefLabel

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@ast

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@en

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@nl

P1433

Q26999424-36E441ED-54DE-4911-9799-B4B5F79B97B9

P1476

Q26999424-52F379AD-A573-412A-AEAC-715934D4C96A

P2093

Q26999424-48CD0D58-06AA-48AE-867B-7B66C6E2BBA3

P275

Q26999424-0A338251-49F3-4A17-8E1E-3ECFB6193862

P2860

Q26999424-0069CF78-55AE-4688-BF6C-F161CE714448

Q26999424-02B12EF6-72AC-4D52-A017-2B46C492007F

Q26999424-063E9686-1E9C-4127-822D-0CE7A4E3B2B1

Q26999424-0698E1B4-7FEB-47B1-9383-90F616996602

Q26999424-0834C6C1-799A-4C6B-BCB5-4B2F7F23E196

Q26999424-12272A52-EAD9-43C0-8AD7-2BD4057500B5

Q26999424-161F8957-0516-4F49-85C9-BE482D32DBB7

Q26999424-168575C4-5378-48EB-9C0A-7D74C2EB713E

Q26999424-171EB04A-8545-4341-B1F8-56FDC1BEE474

Q26999424-1725F630-CD46-4B9F-960B-9E537A50539E

P2888

Q26999424-876649D2-16C3-4CE8-AA71-36021CD6D801

P304

Q26999424-80F547BF-51CD-473F-802D-1A17923001DB

P31

Q26999424-A75814C6-CFAD-42C5-94EC-9C168F59F66F

Q26999424-E7F8B523-13DE-4A3A-87C9-1E4CAF84B669

P3181

Q26999424-B59E504C-56A7-43F0-80E0-D503758F3AF8

P356

Q26999424-3E05D047-B19B-46DB-A56F-FAC89A80B1C0

P407

Q26999424-1863237D-3197-4D42-96C0-E73DB394A443

P478

Q26999424-12FFCB31-EF71-4D2B-A374-9C7D4DC2EBA4

P5008

Q26999424-F14E0762-F35C-47E1-8DE3-E24F987968C1

P577

Q26999424-FF72E2E9-851E-4A2D-BB6A-8352838A7571

P5875

Q26999424-4547A055-E429-420D-AB16-14FF64E17AFB

P6179

Q26999424-30C60C85-A4C3-4789-AC51-01E726BE291C

P698

Q26999424-5B0B83C8-757A-4508-B16E-64526E1B67B0

P921

Q26999424-49D53C02-3522-4219-97A0-1A09DEA54D00

Q26999424-73C12100-FD02-42E9-A1B5-D1F30C5F1BC6

Q26999424-88FAF4F7-B472-44DB-BB79-B47CD77B49AF

Q26999424-91CB5DEB-D1DE-460A-96CD-4D723200A3FD

Q26999424-F06B94B4-1079-456A-8226-90EF44E7DEF5

P932

Q26999424-77A59DCF-7934-4FFC-AFBA-1014E6A6410E

P3181

P356

1532-429X-14-13

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

@en

P2093

Martin S Maron

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy

The Genetic Basis for Cardiomyopathy

Apical hypertrophic cardiomyopathy: diagnosed by cardiac magnetic resonance imaging.

Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study.

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

P2888

1532-429x-14-13

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4042898

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1532-429X-14-13

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221797994

http://www.w3.org/2001/XMLSchema#string

P6179

1050811415

http://www.w3.org/2001/XMLSchema#string

P698

22296938

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

hypertrophic cardiomyopathy

familial hypertrophic cardiomyopathy

human musculoskeletal system

P932

3293092

http://www.w3.org/2001/XMLSchema#string